On 20 June 2024, a high-level event co-hosted in Paris by the Government of France, the African Union and Gavi, the Vaccine Alliance, along with the support of Team Europe, will launch the African Vaccine Manufacturing Accelerator (AVMA), an initiative that will provide financial incentives to help vaccine manufacturers in Africa scale up production and become sustainable on a long-term basis.

The event will also make the case for donors to invest in a new era of immunisation with the launch of Gavi’s investment opportunity for 2026–2030.